Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer.

3.7 months); however, the PFS results in this subgroup analysis did not reach statistical significance, due to the reduced statistical power associated with the small sample size.

also in 111,027 other papers